Showing posts with label #HealthEquity. Show all posts
Showing posts with label #HealthEquity. Show all posts

Friday, May 24, 2024

πŸŒ™ IMSPARK: Vigilance: Pacific Strategies for Preventing Sudden Sleep-Related DeathsπŸŒ™

πŸŒ™ Imagine... Vigilance: Pacific Strategies for Preventing Sudden Sleep-Related DeathsπŸŒ™

πŸ’‘ Imagined Endstate: 

A future where Pacific communities are equipped with knowledge and resources to prevent sudden sleep-related deaths, ensuring healthier lives for all.

πŸ”— Link: 

πŸ“š Source: 

Peters, B., MD. (2023, June 27). Why do people die in their sleep? Retrieved from Verywell Health. https://www.verywellhealth.com/why-do-people-die-in-their-sleep-4098302

πŸ’₯ What’s the Big Deal: 

Dying in your sleep, also known as nocturnal death, is most often associated with sudden cardiac arrest and the progressive loss of heart function associated with congestive heart failure (CHF)❤️. Lung failure and an end-stage or terminal disease are other reasons people may die in their sleep.

Here are some key factors contributing to sudden sleep-related deaths:

 

Cardiac Arrest: Cardiac arrest occurs when the heart suddenly stops beating. The risk of death is higher during sleep because emergency medical response is usually too late. Roughly 22% of sudden cardiac arrests occur between 10:00 p.m. and 6:00 a.m. Heart attack, arrhythmia, congestive heart failure, and stroke can lead to sudden cardiac arrestπŸ›Œ.

Arrhythmias: Irregular heart rhythms (arrhythmias) are a common cause of sudden death during sleep. Disruptions in the heart’s electrical system prevent it from pumping blood effectively🩸. Asystole (no detectable electrical activity), atrial fibrillation, and ventricular tachycardia can be fatal. 

Congestive Heart Failure: Gradual heart failure can lead to cardiac arrest. In severe cases, it results in sudden death. Congestive heart failure affects the heart’s ability to pump blood efficiently. 

Heart Attack: Acute heart attacks from coronary heart disease (CHD) are a leading cause of sudden death. Major blockages in heart arteries decrease blood flow and oxygen supply🌬️, leading to tissue damage and cardiac arrest. 

Risk Factors: Risk factors for sudden death include defects in heart nerve fibers, diseased heart muscle, electrolyte imbalances, thyroid disease, sleep apnea, high blood pressure, stress, and medications. 

Symptoms: Symptoms of arrhythmias include fluttering in the chest, fast heartbeat, skipped heartbeats, palpitations, chest pain, shortness of breath, and dizziness😡. Recognizing these symptoms can lead to timely treatment and prevention. 

Community Awareness: Imagine a Pacific where communities actively educate themselves about heart health, recognize warning signs, and take preventive measures🏘️. By promoting awareness, we can reduce the incidence of sudden sleep-related deaths and ensure healthier lives for all.

#PacificHealth,#SleepAwareness,#CommunityResilience,#PreventSuddenDeaths,#HealthEquity,#CulturalWellness,#Empowerment,#IMSPARK,

Friday, May 17, 2024

πŸ’Š IMSPARK: Equity: Biopharma’s Role in Pacific ProsperityπŸ’Š

πŸ’Š Imagine... Equity: Biopharma’s Role in Pacific ProsperityπŸ’Š



πŸ’‘ Imagined Endstate

A Pacific region where every individual has equitable access to life-saving medicines and healthcare innovations, regardless of their economic status.

πŸ”— Link:

πŸ“š Source

Benesty, J., Shah, S., & Osih, R. (2024). How biopharma can make a difference in health equity. BCG.

πŸ’₯ What’s the Big Deal

In the Pacific, where island nations grapple with pressing healthcare challenges, the role of biopharma companies is not just significant; it's urgent. Over 2 billion people in low—and middle-income countries lack access to medicines,🌏a disparity projected to escalate rapidly in the coming years. This healthcare access gap is not merely a challenge; it's a pressing call for biopharma companies to step up, drive change, and make a tangible impact.

Imagine a Pacific where health equity is the norm, and biopharma companies are the catalysts of this transformation.πŸŒ… By overcoming barriers to adaptation, availability, affordability, and adoption, these companies can ensure that life-saving drugs are within reach of those in dire need, thereby revolutionizing healthcare in the Pacific.

The Pacific's untapped market presents a win-win situation for biopharma companies seeking growth and communities in need of medicines. For instance, the insulin market, valued at billions, is currently inaccessible to half of the patients who need it.πŸ₯ By addressing even a fraction of this demand, companies could not only generate substantial revenue but also save numerous lives, making it a lucrative and impactful investment opportunity.

The big deal is the transformative potential of biopharma in the Pacific. It's about reversing the tide of health inequities and envisioning a future where no one is left behind due to lack of access to healthcare. It's about harnessing innovative business models,πŸ“ˆ forging strategic partnerships, and gaining a deeper understanding of what is required to create a healthier, more prosperous Pacific.


#BiopharmaEquity,#HealthEquity, #PacificHealthcare,#InnovationForAll, #Medicine,#SustainableHealthcare, #CommunityProsperity, #IMSPARK,


πŸ”¬ IMSPARK: Unveiling New Climate InsightsπŸ”¬

πŸ”¬ Imagine... Unveiling New Climate InsightsπŸ”¬ πŸ’‘ Imagined Endstate :  A world enlightened by groundbreaking climate science, guiding target...